We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Pathology

DB function failed with error number 0

Spatial Map Guides Treatment Selection in Muscle-Invasive Bladder Cancer

More...
19 Jun 2026
Image: Healthy and cancerous regions in a H&Eble results (Photo courtesy of KAUST)

Stain-Free Imaging Platform Matches Standard Cancer Pathology

A stain-free imaging system achieves 99% diagnostic concordance, cuts prep time up to 50%, and standardizes data. More...
16 Jun 2026
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Roche’s VENTANA PTEN (SP218) RxDx Assay is the first FDA-approved IHC companion diagnostic for detecting PTEN protein loss in prostate adenocarcinoma. More...
15 Jun 2026
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

An imaging and AI platform automates HER2 scoring and flags cases that may need further review,. More...
12 Jun 2026
Image: The new AI system classifies 102 molecular subtypes of CNS tumors from digitized, routinely stained histology sections (Image credit: iStock)

AI Tool Speeds Brain Tumor Classification from Routine Histology Slides

An AI approach classifies a wide range CNS tumor subtypes from routine slides in minutes. More...
11 Jun 2026
Image: Used as a predictive biomarker, VENTANA MMR RxDx Panel helps identify cancer patients eligible for certain precision oncology therapies, with IVDR approval expanding the companion diagnostic’s label to five cancer types and six indication (Photo courtesy of Roche)

IHC Companion Diagnostic Standardizes Mismatch Repair Testing for Cancer Immunotherapy

An IVDR-approved immunohistochemistry panel standardizes mismatch repair testing and enables therapy selection across multiple solid tumors. More...
11 Jun 2026
Image: Findings demonstrate that AI can help classify meningiomas by extracting molecular and prognostic information from standard H&E slides already used in routine care. (Image Credit: Mikael Häggström, M.D./Wikimedia Commons, CC0 1.0)

AI Pathology Tool Predicts Meningioma Recurrence from Routine Slides

An AI approach reads routine H&E slides to classify meningiomas and predict recurrence. More...
10 Jun 2026
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Automated Clinical Chemistry Analyzer
Envoy 500+
Electrolyte Analyzer
BKE-B


The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
Copyright © 2000-2026 Globetech Media. All rights reserved.